| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to innovation: Is there a difference in the use of expensive anticancer drugs between French hospitals?
|
Bonastre, Julia
|
|
2014
|
116 |
2-3 |
p. 162-169
8 p.
|
artikel
|
| 2 |
An international survey of assisted reproductive technologies (ARTs) policies and the effects of these policies on costs, utilization, and health outcomes
|
Dunn, Andrea L.
|
|
2014
|
116 |
2-3 |
p. 238-263
26 p.
|
artikel
|
| 3 |
Brand loyalty, patients and limited generic medicines uptake
|
Costa-Font, Joan
|
|
2014
|
116 |
2-3 |
p. 224-233
10 p.
|
artikel
|
| 4 |
Characteristics of physicians and patients who join team-based primary care practices: Evidence from Quebec's Family Medicine Groups
|
Coyle, Natalie
|
|
2014
|
116 |
2-3 |
p. 264-272
9 p.
|
artikel
|
| 5 |
Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY
|
Nord, Erik
|
|
2014
|
116 |
2-3 |
p. 281-288
8 p.
|
artikel
|
| 6 |
Contents
|
|
|
2014
|
116 |
2-3 |
p. CO4-
1 p.
|
artikel
|
| 7 |
Does feedback influence patient - professional communication? Empirical evidence from Italy
|
Murante, Anna Maria
|
|
2014
|
116 |
2-3 |
p. 273-280
8 p.
|
artikel
|
| 8 |
Early benefit assessment of new drugs in Germany – Results from 2011 to 2012
|
Hörn, Helmut
|
|
2014
|
116 |
2-3 |
p. 147-153
7 p.
|
artikel
|
| 9 |
Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study
|
Hsu, Jason C.
|
|
2014
|
116 |
2-3 |
p. 196-205
10 p.
|
artikel
|
| 10 |
Is there any evidence that the Trans Pacific Partnership Agreement will threaten access to affordable medicines and health equity in New Zealand?
|
Wonder, Michael
|
|
2014
|
116 |
2-3 |
p. 234-235
2 p.
|
artikel
|
| 11 |
Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007
|
Puig-Junoy, Jaume
|
|
2014
|
116 |
2-3 |
p. 170-181
12 p.
|
artikel
|
| 12 |
Physician and pharmacist perceptions of generic medicines: What they think and how they differ
|
Dunne, Suzanne
|
|
2014
|
116 |
2-3 |
p. 214-223
10 p.
|
artikel
|
| 13 |
Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups
|
Vivas-Consuelo, David
|
|
2014
|
116 |
2-3 |
p. 188-195
8 p.
|
artikel
|
| 14 |
Recognition of pharmaceutical prescriptions across the European Union: A comparison of five Member States’ policies and practices
|
Miguel, Lorena San
|
|
2014
|
116 |
2-3 |
p. 206-213
8 p.
|
artikel
|
| 15 |
Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices
|
Curto, Sandro
|
|
2014
|
116 |
2-3 |
p. 182-187
6 p.
|
artikel
|
| 16 |
Reply by authors
|
Gleeson, Deborah
|
|
2014
|
116 |
2-3 |
p. 236-237
2 p.
|
artikel
|
| 17 |
Systematic review of factors affecting pharmaceutical expenditures
|
Mousnad, Mohamed Awad
|
|
2014
|
116 |
2-3 |
p. 137-146
10 p.
|
artikel
|
| 18 |
The characteristics and fulfillment of conditional prescription drug approvals in Canada
|
Law, Michael R.
|
|
2014
|
116 |
2-3 |
p. 154-161
8 p.
|
artikel
|
Tijdschrift beschrijving